NCT06288308View on ClinicalTrials.gov

Fibrinogen to Albumin Ratio (FAR) as a Predictive Biomarker for Lupus Nephritis (LN)

Not yet recruitingOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

March 20, 2024

Primary Completion Date

November 30, 2024

Study Completion Date

December 31, 2024

Conditions
Lupus Nephritis
Interventions
DIAGNOSTIC_TEST

fibronigin to albumin ratio

"To investigate the association of fibrinogen to albumin ratio (FAR) with LN in different classes.~b. Secondary (subsidiary):~To prove the possible role of FAR as a novel diagnostic biomarker to predict LN progression"

All Listed Sponsors
lead

Assiut University

OTHER

NCT06288308 - Fibrinogen to Albumin Ratio (FAR) as a Predictive Biomarker for Lupus Nephritis (LN) | Biotech Hunter | Biotech Hunter